SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,000 | -4.3% | 300 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $23,000 | -14.8% | 300 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $27,000 | -3.6% | 300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $28,000 | +21.7% | 300 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $23,000 | +4.5% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $22,000 | -56.9% | 300 | 0.0% | 0.01% | -58.8% |
| Q4 2020 | $51,000 | +21.4% | 300 | 0.0% | 0.02% | +6.2% |
| Q3 2020 | $42,000 | -12.5% | 300 | 0.0% | 0.02% | -20.0% |
| Q2 2020 | $48,000 | +65.5% | 300 | 0.0% | 0.02% | +33.3% |
| Q1 2020 | $29,000 | -23.7% | 300 | 0.0% | 0.02% | -11.8% |
| Q4 2019 | $38,000 | +65.2% | 300 | 0.0% | 0.02% | +41.7% |
| Q3 2019 | $23,000 | -50.0% | 300 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $46,000 | -23.3% | 300 | -40.0% | 0.02% | -22.6% |
| Q1 2019 | $60,000 | +11.1% | 500 | 0.0% | 0.03% | -3.1% |
| Q4 2018 | $54,000 | -33.3% | 500 | 0.0% | 0.03% | -25.6% |
| Q3 2018 | $81,000 | – | 500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |